Role of fluoxetine in anorexia nervosa

Annals of Pharmacotherapy

Volumn 37, Issue 6, 2003, Pages 890-892

  Kim, Sara S ^a,b,c  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Anorexia nervosa; Fluoxetine; Selective serotonin reuptake inhibitors

Indexed keywords

AMFEBUTAMONE; CHLORPROMAZINE; CITALOPRAM; CYPROHEPTADINE; FLUOXETINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGITATION; ANOREXIA NERVOSA; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIET THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INSOMNIA; MEDLINE; META ANALYSIS; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPY; SCHIZOTYPAL PERSONALITY DISORDER; SHORT SURVEY; SIDE EFFECT; VISUAL IMPAIRMENT; WEIGHT GAIN;

ANIMALS; ANOREXIA NERVOSA; CLINICAL TRIALS; FLUOXETINE; HUMANS;

EID: 0037809568     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C362     Document Type: Short Survey

References (16)

1. Mayer LE, Walsh BT. The use of selective serotonin reuptake inhibitors in eating disorders. J Clin Psychiatry 1998;59(suppl 15):28-34.
2. Diagnostic and statistical manual of mental disorders. 4th ed. test revision (DSM-IV-TR). Washington, DC: American Psychiatric Press, 2000:583-6.
3. Herzog DB, Nussbaum KM, Marmor AK. Comorbidity and outcome in eating disorders. Psychiatr Clin North Am 1996;19:843-59.
4. Theander S. Outcome and prognosis in anorexia nervosa and bulimia: some results of previous investigations compared with those of a Swedish long-term study. J Psychiatr Res 1985;19:493-508.
5. Hudson JI, Pope HG Jr, Jonas JM, Yurgelun-Todd D. Phenomenologic relationship of eating disorders to major affective disorder. Psychiatry Res 1983;9:345-54.
6. Garner DM, Olmsted MP, Garfinkel PE. Does anorexia nervosa occur on a continuum? Subgroup of weight-preoccupied women and their relationship to anorexia nervosa. Int J Eating Disord 1983;2:11-20.
7. Practice guidelines for the treatment of patients with eating disorders (revision). Am J Psychiatry 2000;157(1 suppl):1-39.
8. Kaye WH, Gwirtsman HE, George DT, Ebert MH. Altered serotonin activity in anorexia nervosa after long-term weight restoration: does elevated CSF 5-HIAA correlate with rigid and obsessive behavior? Arch Gen Psychiatry 1991;48:556-62.
9. Ferguson JM. Treatment of an anorexia nervosa patient with fluoxetine (letter). Am J Psychiatry 1987;144:1239.
10. Heiden A, Zwaan M, Frey R, Presslich O, Kasper S. Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder. J Psychiatry Neurosci 1998;23:179-80.
11. Santonastaso P, Friederici S, Favaro A. Sertraline in the treatment of restricting anorexia nervosa: an open controlled trial. J Child Adolesc Psychopharmacol 2001;11:143-50.
12. Fassino S, Leombruni P, Daga GA, Brustolin A, Migliaretti G, Cavallo F, et al. Efficacy of citalopram in anorexia nervosa: a pilot study. Eur Neuropsychopharmacol 2002;12:453-9.
13. Gwirtsman HE, Guze BH, Yager J, Gainsley B. Fluoxetine treatment of anorexia nervosa: an open clinical trial. J Clin Psychiatry 1990;51:378-82.
14. Kaye WH, Weltzin TE, Hsu LK, Bulik CM. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 1991;52:464-71.
15. Kaye WH, Nagata T, Weltzin TE, Hsu LK, Sokol MS, McConaha C, et al. Double-blind placebo-controlled administration of fluoxetine in restricting and restricting-purging type anorexia nervosa. Biol Psychiatry 2001;49:644-52.
16. Attia E, Haiman C, Walsh T, Flater SR. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry 1998;155:548-51.